1. 1) Jumper J., Evans R., Pritzel A., et al. Nature, 596, 583–589 (2021).
2. 2) IBM Watson Health. “Healthcare provider solutions|Watson Health.”: 〈https://www.ibm.com/watson-health/solutions/healthcare-provider〉, cited 20 July, 2022.
3. 3) U.S. Food and Drug Administration. “Artificial Intelligence and Machine Learning (AI/ML) Medical Devices.”: 〈https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices〉, cited 10 October, 2022.
4. 4) Pharmaceuticals and Medical Devices Agency. “AI iryokiki no kaihatsu joukyo tou nitsuite.”: 〈https://www.pmda.go.jp/files/000244149.pdf〉, cited 21 July, 2022.
5. 5) Pharmaceuticals and Medical Devices Agency. “Japanese Adverse Drug Event Report database: [data-set no download page] de teikyo suru joho nitsuite.”: 〈https://www.pmda.go.jp/safety/info-services/drugs/adr-info/suspected-adr/0004.html〉, cited 17 July, 2022.